Back to results
US 8,283,471 B2Granted
Succinate salt of 2-((4-(1-methyl-4-pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline
AssigneePfizer Inc.
InventorsCaroline Proulx-Lafrance, Patrick Robert Verhoest
Life of this patent
Estimating the term…
Abstract
The present invention relates to a succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline, and to a method for treating disorders of the Central Nervous System (CNS) and other disorders in a mammal, including a human, by administering to the mammal the succinate salt. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier and the succinate salt.
Claims9
A succinate salt of Formula I:
- wherein the salt has characteristic X-ray powder diffraction peaks as measured with copper radiation of 2-Theta±0.1° of 15.8, 21.0 and 26.6.
Dependencies are inferred from the claim text.